|
Volumn 10, Issue 2, 2001, Pages 85-94
|
Methylphenidate in children with hyperactivity: Review and cost-utility analysis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
METHYLPHENIDATE;
PLACEBO;
ADOLESCENCE;
ADULTHOOD;
ANOREXIA;
ARTICLE;
CHILD;
CHILD CARE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
COST UTILITY ANALYSIS;
CRYING;
DISEASE CLASSIFICATION;
DRUG COST;
DRUG EFFICACY;
HEADACHE;
HUMAN;
HYPERACTIVITY;
INSOMNIA;
MEDICAL LITERATURE;
METHODOLOGY;
MODEL;
NATIONAL HEALTH SERVICE;
PRIORITY JOURNAL;
QUALITY ADJUSTED LIFE YEAR;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SHORT COURSE THERAPY;
SIDE EFFECT;
STOMACH PAIN;
TIC;
TREATMENT OUTCOME;
VERTIGO;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
CHILD;
COSTS AND COST ANALYSIS;
GREAT BRITAIN;
HUMANS;
METHYLPHENIDATE;
QUALITY-ADJUSTED LIFE YEARS;
RANDOMIZED CONTROLLED TRIALS;
SENSITIVITY AND SPECIFICITY;
SYMPATHOMIMETICS;
|
EID: 0034960256
PISSN: 10538569
EISSN: None
Source Type: Journal
DOI: 10.1002/pds.564 Document Type: Article |
Times cited : (54)
|
References (45)
|